Latest Bevacizumab Stories
- Annual Revenues Increased 18 Percent during 2013 - INCLINE VILLAGE, Nev., March 3, 2014 /PRNewswire/ -- PDL BioPharma, Inc.
Interim clinical data to be presented at American Association of Cancer Research (AACR) Annual Meeting on April 9, 2014 VANCOUVER, British Columbia and MENLO PARK, Calif., Feb.
DALLAS, February 21, 2014 /PRNewswire/ -- RnRMarketResearch.com offers cancer monoclonal antibodies market (mABs) research reports covering pipeline analysis as well as
CAMBRIDGE, Mass., Feb.
INCLINE VILLAGE, Nev., Feb. 3, 2014 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has entered into an agreement with Genentech, Inc. (Genentech) and F.
HAIFA, Israel, Jan.
A new study published online today in The Oncologist journal shows that an assessment of metabolic response in patients with metastatic colon cancer (mCC) treated with a single course of chemotherapy
CAMBRIDGE, Mass., Jan.
Frost & Sullivan: Ripe for innovative, non-invasive treatments, the market will almost double by 2017 MOUNTAIN VIEW, Calif., Jan.
- The act of sweetening by admixture of some saccharine substance.